Kadcyla (ado-trastuzumab emtansine) - Roche
Jivadco (trastuzumab duocarmazine) - Byondis, Medac
Tukysa (tucatinib) - Seagen
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
Nerlynx (neratinib) - Puma, Knight Therap, Pierre Fabre
http://www.ncbi.nlm.nih.gov/pubmed/37760491
 
Ana Lameirinhas; Ana Lluch; Anna Ágreda-Roca; Begoña Bermejo; Cristina Hernando; Cristina Tebar-Sánchez; Iris Garrido-Cano; Maria Teresa Martinez; Marta Tapia; Octavio Burgués; Pilar Eroles; Sandra Torres-Ruiz
 
Sep 28, 2023
 
Prev Next